Sawalmeh, O., Moala, S., Hamdan, Z., Masri, H., Ayoub, K., Khazneh, E., & Shraim, M. (2018). Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: A randomized controlled trial. Int J Nephrol Renovasc Dis.
Citação norma ChicagoSawalmeh, Osama, Shaheed Moala, Zakaria Hamdan, Huda Masri, Khubaib Ayoub, Emad Khazneh, and Mujahed Shraim. "Pulse Versus Daily Oral Alfacalcidol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Controlled Trial." Int J Nephrol Renovasc Dis 2018.
Citação norma MLASawalmeh, Osama, et al. "Pulse Versus Daily Oral Alfacalcidol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A Randomized Controlled Trial." Int J Nephrol Renovasc Dis 2018.